Drug Database
Back to search

Canada· CA-DIN-02371057

TWYNSTA

A telmisartan and amlodipine product containing telmisartan + amlodipine (amlodipine besylate), registered in Canada by BOEHRINGER INGELHEIM (CANADA) LTD LTEE. The same ATC class is registered in 11 of our 19 countries.

ATC C09DB04

Checked against Health Canada Drug Product Database (Canada) on

Informational only — not a medical device.

SOURCE REGISTER · CAHealth Canada Drug Product Database (Ca…normalisedTWYNSTAATCC09DB04REGISTER NO.CA-DIN-02371057PACKS LISTED0CHECKEDOctober 1, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about telmisartan + amlodipine (amlodipine besylate)Answers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Telmisartan and amlodipine is registered in 11 of 19 countries.

Countries holding a registration under ATC C09DB04 (telmisartan and amlodipine), each read from that country’s own register.

  • This record: Canada, from Health Canada Drug Product Database (Canada)
  • 7 of them publish a price we can compare per daily dose
Search telmisartan and amlodipine products by name

Telmisartan and amlodipine · ATC C09DB04

11 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Polandprice
  • Switzerlandprice
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Health Canada Drug Product Database (Canada)
Active substance
TELMISARTAN + AMLODIPINE (AMLODIPINE BESYLATE)
Manufacturer
BOEHRINGER INGELHEIM (CANADA) LTD LTEE
Country
Canada (CA)
ATC code
C09DB04
ATC class
Telmisartan and amlodipine
Reimbursed
Not published by this register
Source register
Health Canada Drug Product Database (Canada)
Last checked
October 1, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

46 interactions on record for telmisartan and amlodipine.

Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check telmisartan and amlodipine against other medicinesHow interaction checks work

Telmisartan and amlodipine · interactions on record

46 records

46 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
Mechanism and what to do, in the interaction check
Interaction register. Grades as the source publishes them.

Same medicine, other countries

Telmisartan and amlodipine in 12 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All telmisartan and amlodipine products

Authorised across Europe · EMA

The same active substance is authorised in 19 EEA countries. Names it is sold under:

  • Austria · Telmisartan/Amlodipin Krka
  • Bulgaria · Актелсар Дуо, Равентон
  • Czechia · Tamloset, Telassmo
  • Germany · Actelsar Duo, Telmisartan/Amlodipin 089pharm
  • Estonia · Mixor, Teldipin
  • Spain · Telmisartán/Amlodipino Krka, Telmisartán/Amlodipino Teva
  • France · Telmisartan/Amlodipine Arrow
  • Greece · Cardynsta
  • Hungary · Arettan, Cotanydon
  • Iceland · Twynsta
  • Liechtenstein · Twynsta
  • Lithuania · Raventon
  • Latvia · Mixor, Raventon
  • Norway · Twynsta
  • Poland · Telam, Teldipin
  • Portugal · Amlodipina + Telmisartan Generis, Amlodipina + Telmisartan Krka
  • Romania · Telassmo
  • Slovenia · Telassmo
  • Slovakia · Mixor, Teldipin

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Health Canada Drug Product Database (Canada). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/89989fc5-00c2-4590-a380-c5c8fca7427e
GET /v1/drugs/89989fc5-00c2-4590-a380-c5c8fca7427e?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "din": "02371057",
  "form": "TABLET",
  "class": "Human",
  "routes": [
    "ORAL"
  ],
  "source": "health_canada_dpd",
  "status": "MARKETED",
  "atc_raw": "C09DB04",
  "schedule": [
    "Prescription"
  ],
  "drug_code": "85625",
  "strengths": [
    "80 MG",
    "10 MG"
  ],
  "ahfs_class": null,
  "substances": [
    "TELMISARTAN",
    "AMLODIPINE (AMLODIPINE BESYLATE)"
  ],
  "product_categorization": null
}
API referenceMCP serverPlans

See everything about telmisartan and amlodipine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console